Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Efficacy and Patient Reported Outcomes of Advanced Breast Cancer Patients: Therapy Management With Nab-Paclitaxel in Daily Routine - SERAPHINA

NCT02642406 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT02642406
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02642406 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Efficacy and Patient Reported Outcomes of Advanced Breast Cancer Patients: Therapy Management With Nab-Paclitaxel in Daily Routine - SERAPHINA
Lead sponsor
University Hospital Tuebingen
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2015
Completion date
December 31, 2021
Enrollment
1,200 (estimated)
Sites
83

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer